Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2

Journal Article · · Cell Reports

Research Organization:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Organization:
~OTHER
DOE Contract Number:
SC0012704
OSTI ID:
1808996
Report Number(s):
BNL-221891-2021-JACI
Journal Information:
Cell Reports, Vol. 35, Issue 6
Country of Publication:
United States
Language:
English

References (66)

PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Shaping a universally broad antibody response to influenza amidst a variable immunoglobulin landscape journal August 2018
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies journal October 2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies journal August 2020
Commonality despite exceptional diversity in the baseline human antibody repertoire journal January 2019
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability journal June 2020
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals journal January 2021
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells journal July 2020
VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design journal February 2019
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 journal June 2020
Principles that Determine the Structure of Proteins journal June 1984
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy journal November 2020
Effectiveness of convalescent plasma therapy in severe COVID-19 patients journal April 2020
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses journal July 2011
Features and development of Coot journal March 2010
Cellular and genetic mechanisms of self tolerance and autoimmunity journal June 2005
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail journal June 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor journal April 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike journal September 2020
Human neutralizing antibodies elicited by SARS-CoV-2 infection journal May 2020
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro journal January 2007
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients journal August 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model journal November 2020
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Structural patterns in globular proteins journal June 1976
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity journal September 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike journal July 2020
Beyond binding: antibody effector functions in infectious diseases journal October 2017
Phaser crystallographic software journal July 2007
Receptor editing in lymphocyte development and central tolerance journal October 2006
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Convergent Antibody Signatures in Human Dengue journal June 2013
Public antibodies to malaria antigens generated by two LAIR1 insertion modalities journal August 2017
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody journal May 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients journal June 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike journal October 2020
Clonal selection and learning in the antibody system journal June 1996
Convergent antibody responses to SARS-CoV-2 in convalescent individuals journal June 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model journal June 2020
Antibody therapies for the prevention and treatment of viral infections journal July 2017
Antibody-mediated protection against Ebola virus journal October 2018
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo journal November 2020
Repertoire Builder: high-throughput structural modeling of B and T cell receptors journal January 2019
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans journal October 2020
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection journal June 2018
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation journal July 2020
Structural basis of receptor recognition by SARS-CoV-2 journal March 2020
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma journal April 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 journal May 2020
High frequency of shared clonotypes in human B cell receptor repertoires journal February 2019
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine journal March 2020
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants journal July 2006
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody journal January 2020
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein journal April 2020
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection journal July 2020
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain journal October 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 journal May 2020
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection journal December 2020
IgBLAST: an immunoglobulin variable domain sequence analysis tool journal May 2013
Structural basis of a shared antibody response to SARS-CoV-2 journal July 2020
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV journal April 2020
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies journal January 2021
A pneumonia outbreak associated with a new coronavirus of probable bat origin journal February 2020
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera journal April 2021
Potently neutralizing and protective human antibodies against SARS-CoV-2 journal July 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein journal July 2020